Choose your location

Latest
Sheryl Crow reveals 'incredible' Welsh heritage US midterm elections 2026 live updates: Trump ignores midterms in first remarks after stunning Republican losses; Vance blames Iran war Manchester United v Roma: Champions League – live WPIAL football playoffs primer: Top games, players to watch, upset alerts and predictions Another child dies of measles as CDC reportedly holds up health alert John Lewis Christmas ad stars Kristin Scott Thomas as glamorous granny on a gift hunt

Kudzu supplement helps people cut back on binge drinking

An herbal supplement made from kudzu, a plant long used in traditional medicine from East Asia, may offer a new way to help people cut back on binge drinking, according to a UC San Francisco study.

News-Medical

An herbal supplement made from kudzu, a plant long used in traditional medicine from East Asia, may offer a new way to help people cut back on binge drinking, according to a UC San Francisco study. Researchers found that people with alcohol use disorder who took kudzu when they expected they might drink heavily had fewer binge-drinking days than those who received a placebo.

The benefits were still evident after three months, when the treatment had ended. Binge drinking is a major public health problem, accounting for more than half of the roughly 80,000 annual U.S. deaths attributed to excessive alcohol consumption. Yet fewer than 10% of people with alcohol use disorder have ever received medication to treat it.

Binge drinking is incredibly common, but we don't have many tools to offer people who want to cut back. Our goal is to expand that toolkit. What'sexciting about this approach is that people can use it when they know they may be at risk of heavy drinking, rather than taking a medication every day." Glenn-Milo Santos, PhD, MPH, study's lead author and UCSF professor of community health systems The study, published in the American Journal of Psychiatry on Nov.

4, included 120 adults with alcohol use disorder who binge drank at least once a week. For men, binge drinking was defined as having five or more drinks on one occasion, and for women, it was four or more. Half the participants received a standardized kudzu extract and half received a placebo.

For 12 weeks, they were instructed to take the treatment about 2.5 hours before they expected to drink heavily. Both groups also received brief weekly counseling sessions. Related Stories Why one gut microbe is attracting attention in heart failure research College BORG drinking associated with blackouts and other alcohol-related harms New research shows reduced toxicant exposure reduces biological activity By the end of treatment, the average number of binge-drinking days had fallen from 2.15 to 1.42 per week in the kudzu group.

They hardly changed in the placebo group, going from 2.15 to 2.06. Moreover, the proportion of weeks in which participants reported any binge drinking also declined markedly in the kudzu group, from 88% to 58%, compared with a much smaller change in the placebo group, from 88% to just 81%.

Three months after treatment stopped, people assigned to take kudzu continued to have significantly fewer binge-drinking days than those who were assigned to get the placebo. Researchers said reducing alcohol use during treatment may have helped participants rethink their relationship with alcohol and build confidence in their ability to drink less.

The participants tolerated taking kudzu and had no more side effects than those in the placebo group. Nor were any serious side effects linked to the treatment. Researchers caution that consumers should not assume commercially available kudzu supplements will produce the same results.

The study used a standardized formulation, while over-the-counter products can vary. Larger studies are needed to confirm the findings in broader populations. Source: Journal reference: Santos, G.-M., et al . (2026).

Targeted Use of Kudzu for Binge Drinking Among Adults With Alcohol Use Disorder: A Phase 2b Randomized Trial. American Journal of Psychiatry . DOI: 10.1176/appi.ajp.20251354. https://psychiatryonline.org/doi/10.1176/appi.ajp.20251354 Suggested Reading Terms While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses.

Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided. Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information. Read the full Terms & Conditions .

Article text via FreeNewsAPI. Rights remain with News-Medical.

Read on publisher site → Opens News-Medical in a new tab

More in Local